STRONGBRIDGE BIOPHARMA plc Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
STRONGBRIDGE BIOPHARMA plc reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$25.05 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-06-30 was -$13.24M.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$11.81M.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$11.95M.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was -$3.16M.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$45.08M.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$49.45M, a 255.26% decline from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was $31.85M.
- STRONGBRIDGE BIOPHARMA plc net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$113.48M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2021-06-30 | -$13.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$25.05M 10-Q · filed 2021-08-05 | -$37.00M derived: sum of 3 quarters · filed 2021-08-05 | -$40.16M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2021-03-31 | -$11.81M 10-Q · filed 2021-05-12 | -$23.76M derived: sum of 2 quarters · filed 2021-05-12 | -$26.92M derived: sum of 3 quarters · filed 2021-05-12 | -$44.19M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-12-31 | -$11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$15.11M derived: sum of 2 quarters · filed 2021-03-03 | -$32.38M derived: sum of 3 quarters · filed 2021-08-05 | -$45.08M 10-K · filed 2021-03-03 | |
| 2020-09-30 | -$3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$20.43M derived: sum of 2 quarters · filed 2021-08-05 | -$33.13M 10-Q · filed 2020-10-29 | -$42.11M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-06-30 | -$17.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$29.97M 10-Q · filed 2021-08-05 | -$38.95M derived: sum of 3 quarters · filed 2021-08-05 | -$52.74M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$12.70M 10-Q · filed 2021-05-12 | -$21.68M derived: sum of 2 quarters · filed 2021-05-12 | -$35.47M derived: sum of 3 quarters · filed 2021-05-12 | -$43.72M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$22.77M derived: sum of 2 quarters · filed 2021-03-03 | -$31.02M derived: sum of 3 quarters · filed 2021-03-03 | -$49.45M 10-K · filed 2021-03-03 | |
| 2019-09-30 | -$13.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$22.04M derived: sum of 2 quarters · filed 2020-10-29 | -$40.47M 10-Q · filed 2020-10-29 | $43.59M derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-06-30 | -$8.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$26.68M 10-Q · filed 2020-08-04 | $57.38M derived: sum of 3 quarters · filed 2020-08-04 | $36.82M derived: sum of 4 quarters · filed 2020-08-04 | |
| 2019-03-31 | -$18.43M 10-Q · filed 2020-05-06 | $65.62M derived: sum of 2 quarters · filed 2020-05-06 | $45.06M derived: sum of 3 quarters · filed 2020-05-06 | $42.14M derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | $84.06M 10-K · filed 2019-02-27 | $63.50M derived: sum of 2 quarters · filed 2019-02-27 | $60.57M derived: sum of 3 quarters · filed 2019-02-27 | $31.85M 10-K · filed 2021-03-03 | |
| 2018-09-30 | -$20.56M 10-K · filed 2019-02-27 | -$23.48M derived: sum of 2 quarters · filed 2019-02-27 | -$52.20M 10-Q · filed 2019-11-07 | -$70.95M derived: sum of 4 quarters · filed 2019-05-01 | |
| 2018-06-30 | -$2.92M 10-K · filed 2019-02-27 | -$31.65M 10-Q · filed 2019-07-31 | -$50.39M derived: sum of 3 quarters · filed 2019-05-01 | -$85.45M derived: sum of 4 quarters · filed 2019-05-01 | |
| 2018-03-31 | -$28.72M 10-Q · filed 2019-05-01 | -$47.47M derived: sum of 2 quarters · filed 2019-05-01 | -$82.53M derived: sum of 3 quarters · filed 2019-05-01 | -$112.72M derived: sum of 4 quarters · filed 2019-05-01 | |
| 2017-12-31 | -$18.75M 10-K · filed 2019-02-27 | -$53.81M derived: sum of 2 quarters · filed 2019-02-27 | -$84.00M derived: sum of 3 quarters · filed 2019-02-27 | -$113.48M 10-K · filed 2020-02-28 | |
| 2017-09-30 | -$35.06M 10-K · filed 2019-02-27 | -$65.25M derived: sum of 2 quarters · filed 2019-02-27 | -$94.73M 10-Q · filed 2018-10-31 | -$110.74M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | -$30.19M 10-K · filed 2019-02-27 | -$59.67M 10-Q · filed 2018-08-08 | -$75.68M derived: sum of 3 quarters · filed 2019-02-27 | -$83.28M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$29.48M 10-K · filed 2019-02-27 | -$45.49M derived: sum of 2 quarters · filed 2019-02-27 | -$53.09M derived: sum of 3 quarters · filed 2019-02-27 | -$65.93M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | -$16.00M 10-K · filed 2018-03-12 | -$23.60M derived: sum of 2 quarters · filed 2018-03-12 | -$36.44M derived: sum of 3 quarters · filed 2018-03-12 | -$48.72M 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$7.60M 10-K · filed 2018-03-12 | -$7.62M 6-K · filed 2016-12-30 | -$20.44M derived: sum of 2 quarters · filed 2018-03-12 | -$32.72M 6-K · filed 2017-11-14 | -$43.05M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$12.84M 10-K · filed 2018-03-12 | -$12.90M 6-K · filed 2016-12-30 | -$25.10M 6-K · filed 2017-08-07 | -$35.45M derived: sum of 3 quarters · filed 2018-03-12 | -$45.11M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$12.15M 10-K · filed 2018-03-12 | -$12.21M 6-K · filed 2016-05-17 | -$22.60M derived: sum of 2 quarters · filed 2018-03-12 | -$32.27M derived: sum of 3 quarters · filed 2018-03-12 | -$49.41M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$10.45M derived: 10-K 12 month − 6-K 9 month · filed 2018-03-12 | -$20.12M derived: sum of 2 quarters · filed 2018-03-12 | -$37.26M derived: sum of 3 quarters · filed 2018-03-12 | -$43.63M 10-K · filed 2018-03-12 | |
| 2015-09-30 | -$9.67M 6-K · filed 2016-12-30 | -$26.81M derived: sum of 2 quarters · filed 2016-12-30 | -$33.18M 6-K · filed 2016-12-30 | ||
| 2015-06-30 | -$17.14M 6-K · filed 2016-12-30 | -$23.52M 6-K · filed 2016-12-30 | |||
| 2015-03-31 | -$6.37M 6-K · filed 2016-05-17 | ||||
| 2014-12-31 | -$9.67M 20-F · filed 2017-04-04 | ||||
| 2013-12-31 | -$5.39M 20-F · filed 2016-03-24 |